4 March 2016 - The public submission process is now open for the Post-market Reviews of ezetimibe and medicines for COPD. The public submission process will be open for 7 weeks and will close at 5pm Friday, 22 April 2016.

For more details, go to: http://www.pbs.gov.au/info/reviews/post-market-review-chronic-obstructive-pulmonary-disease [COPD medicines]